Sachetta »

Sab Biotherapeutics shares owned by Sachetta

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Sachetta from 13F filings

Historical chart of Sachetta investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Sachetta consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Sachetta

Quarter filed Position value Share count Share price at filing
2024-09-30 $270 100 2.70

More positions owned by Sachetta

Ishares Tr Rus 1000 Etf (IWB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Index Shs Fds Glb Nat Resrce (GNR)
Apple (AAPL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr U.s. Bas Mtl Etf (IYM)
Ishares Tr Rus Mid Cap Etf (IWR)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Mbs Etf (MBB)

View all positions for Sachetta

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Pathstone Holdings
First Manhattan
BlackRock
First PREMIER Bank
Kovitz Investment Group Partners
Institutional & Family Asset Management
BlackRock
Kestra Advisory Services
Citadel Advisors

View all funds holding Sab Biotherapeutics